Start your intake Current Clinical Evidence on GLP-1 and GIP Receptor Dual Therapy Semaglutide monotherapy has demonstrated weight loss of approximately 10-15% body weight in landmark trials like STEP, conducted across diverse populations
By promoting weight loss through lifestyle changes or medications like GLP-1 agonists, women may find relief from both hot flushes and mood-related symptoms, leading to better overall health outcomes
SURMOUNT-4 looked at what happens when you continue treatment versus stopping
Opened and punctured vials Once you puncture the rubber stopper of any tirzepatide vial, the sterility clock starts ticking regardless of the printed expiration date
Available from: Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R, Jones R